IP Library Patent Application 11827278
Patent Application
App. No. 11/827,278

Novel skin staples

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/827,278
Abstract

The present disclosure provides composite staples which include legs made of a bioabsorbable shape memory material capable of gripping tissue upon application in vivo and holding the staple in place.

Claims (32)

1 . A staple comprising:

a backspan comprising a non-absorbable material; and

two leg portions, at least a portion of each of the two leg portions comprising a shape memory polymeric material.

2 . The staple of claim 1 , wherein the non-absorbable material comprises a metal selected from the group consisting of titanium, stainless steel, steel alloys, titanium alloys, nickel chromium alloy, nickel/cobalt/chrome, and combinations thereof.

3 . The staple of claim 1 , wherein the non-absorbable material comprises titanium.

4 . The staple of claim 1 , wherein the shape memory polymer comprises a copolymer of a diol ester and an ether-ester diol.

5 . The staple of claim 1 , wherein the shape memory polymer is selected from the group consisting of oligo (epsilon caprolactone) diol/oligo (p-dioxanone) diol copolymers, lactide, glycolide, and combinations thereof.

6 . The staple of claim 1 , wherein the shape memory polymer comprises a blend of materials selected from the group consisting of urethanes, lactic acid, glycolic acid, acrylates, caprolactones, homopolymers thereof, copolymers thereof, and combinations thereof.

7 . The staple of claim 1 , wherein the shape memory polymer comprises a blend selected from the group consisting of polylactic acid/urethane blends, polyglycolic acid/urethane blends, copolymers of lactic acid and glycolic acid/urethane blends, polycaprolactone dimethacrylate poly(butyl acrylate) blends, and combinations thereof.

8 . The staple of claim 1 , wherein the legs have a permanent memory comprising a bent shape and a temporary memory comprising a straight shape.

9 . The staple of claim 1 , wherein the backspan and the legs are joined by mechanical means selected from the group consisting of tongue and groove frictional coupling means, locking tapers, pins, screws, rivets, and combinations thereof.

10 . The staple of claim 1 , wherein the backspan and the legs are joined by means selected from the group consisting of injection molding, casting from a solvent, melt pressing, the use of bioabsorbable adhesives, and combinations thereof.

11 . The staple of claim 1 , wherein the legs further comprise a medicinal agent.

12 . The staple of claim 11 , wherein the medicinal agent is selected from the group consisting of antimicrobials, analgesics, antipyretics, anesthetics, antiepileptics, antihistamines, anti-inflammatory agents, cardiovascular agents, diagnostic agents, sympathomimetics, cholinomimetics, antimuscarinics, antispasmodics, hemostats, muscle relaxants, adrenergic neuron blockers, antineoplastics, immunogenic agents, immunosuppressants, gastrointestinal drugs, diuretics, steroids, lipids, lipopolysaccharides, polysaccharides, enzymes, local anesthetics, non-steroidal antifertility agents, parasympathomimetic agents, psychotherapeutic agents, tranquilizers, sedative hypnotics, sulfonamides, vaccines, vitamins, antimalarials, anti-migraine agents, anti-parkinson agents, anti-spasmodics, anticholinergic agents, bronchodilators, alkaloids, narcotics, non-narcotics, opioid receptor antagonists, anticoagulants, anti-convulsants, antidepressants, anti-emetics, prostaglandins, cytotoxic drugs, estrogens, antibiotics, anti-fungals, anti-virals, immunological agents, viruses, cells, peptides, polypeptides, proteins, muteins, vaccines, antigens, blood coagulation factors, growth factors, protein inhibitors, protein antagonists, protein agonists, nucleic acids, oligonucleotides, ribozymes, and combinations thereof.

13 . A method comprising:

providing a staple of claim 1 possessing leg portions having a straight, temporary shape;

applying the staple to tissue adjacent a wound; and

heating the leg portions to recover a permanent, bent shape which affixes the staple to tissue adjacent the wound.

14 . The method of claim 13 , wherein heating the leg portions occurs with body heat.

15 . A staple comprising:

a backspan comprising a non-absorbable material selected from the group consisting of titanium, stainless steel, steel alloys, titanium alloys, nickel chromium alloy, nickel/cobalt/chrome, and combinations thereof; and

two leg portions, at least a portion of each of the two leg portions comprising a shape memory polymeric material.

16 . The staple of claim 15 , wherein the shape memory polymer is selected from the group consisting of oligo (epsilon caprolactone) diol/oligo (p-dioxanone) diol copolymers, lactide, glycolide, and combinations thereof.

17 . The staple of claim 15 , wherein the shape memory polymer comprises a blend of materials selected from the group consisting of urethanes, lactic acid, glycolic acid, acrylates, caprolactones, homopolymers thereof, copolymers thereof, and combinations thereof.

18 . The staple of claim 15 , wherein the shape memory polymer comprises a blend selected from the group consisting of polylactic acid/urethane blends, polyglycolic acid/urethane blends, copolymers of lactic acid and glycolic acid/urethane blends, polycaprolactone dimethacrylate poly(butyl acrylate) blends, and combinations thereof.

19 . The staple of claim 15 , wherein the legs have a permanent memory comprising a bent shape and a temporary memory comprising a straight shape.

20 . The staple of claim 15 , wherein the legs further comprise a medicinal agent selected from the group consisting of antimicrobials, analgesics, antipyretics, anesthetics, antiepileptics, antihistamines, anti-inflammatory agents, cardiovascular agents, diagnostic agents, sympathomimetics, cholinomimetics, antimuscarinics, antispasmodics, hemostats, muscle relaxants, adrenergic neuron blockers, antineoplastics, immunogenic agents, immunosuppressants, gastrointestinal drugs, diuretics, steroids, lipids, lipopolysaccharides, polysaccharides, enzymes, local anesthetics, non-steroidal antifertility agents, parasympathomimetic agents, psychotherapeutic agents, tranquilizers, sedative hypnotics, sulfonamides, vaccines, vitamins, antimalarials, anti-migraine agents, anti-parkinson agents, anti-spasmodics, anticholinergic agents, bronchodilators, alkaloids, narcotics, non-narcotics, opioid receptor antagonists, anticoagulants, anti-convulsants, antidepressants, anti-emetics, prostaglandins, cytotoxic drugs, estrogens, antibiotics, anti-fungals, anti-virals, immunological agents, viruses, cells, peptides, polypeptides, proteins, muteins, vaccines, antigens, blood coagulation factors, growth factors, protein inhibitors, protein antagonists, protein agonists, nucleic acids, oligonucleotides, ribozymes, and combinations thereof.

21 . A method comprising:

providing a staple of claim 15 possessing leg portions having a straight, temporary shape;

applying the staple to tissue adjacent a wound; and

heating the leg portions to recover a permanent, bent shape which affixes the staple to tissue adjacent the wound.

22 . The method of claim 15 , wherein heating the leg portions occurs with body heat.

Assignments (2)
CHANGE OF NAME Recorded Oct 2, 2012
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029065/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2007
From: PROMMERSBERGER, MEGAN
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 019737/0138 →